Indevus' Supprelin LA Clears FDA As Once-Yearly Treatment For Premature Puberty

Implant for treatment of central precocious puberty will launch this summer, targeted to pediatric endocrinologists.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet